Search companies or stocks...
THARTharimmune, Inc.
At close · 22 Apr 2026, 04:59 pm
Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.
Tharimmune, Inc., a clinical-stage biotechnology company, engages in the development of therapeutic candidates for rare, inflammatory, and oncologic diseases. The company's…
Current stock price of Tharimmune, Inc. (THAR) stock is $3.540. The stock price is +6.63% higher in the session. The intraday range can be seen from this page. Volume of Tharimmune, Inc. (THAR) stock is 358.85K.
Last updated at 22 Apr 2026, 04:59 pm.
The stock price of Tharimmune, Inc. (THAR) can change with earnings, company news, and overall market sentiment. Tharimmune, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.
Whether Tharimmune, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for THAR on this page is -0.96. EPS on this page is -3.68. Compare those figures with peers and growth expectations before deciding if the current Tharimmune, Inc. price is justified.
Historical performance for Tharimmune, Inc. (THAR) is shown on the price chart on this page. Review multi-period moves alongside volume to see how THAR reacted to past earnings and market events.
Buying Tharimmune, Inc. (THAR) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.
